Case Reports

NPM1 mutation subtype switch in acute myeloid leukemia

CHU Lille, Laboratory of Hematology; Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 – UMR1277 - Canther – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille
CHU Lille, Laboratory of Hematology; Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 – UMR1277 - Canther – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille
CHU Lille, Laboratory of Hematology
CHU Lille, Laboratory of Hematology
Hematology and Cellular Therapy Department, La Conception University Hospital of Marseille, Marseille
CHU Lille, Laboratory of Hematology; Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 – UMR1277 - Canther – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille
CHU Lille, Hematology Department
CHU Lille, Laboratory of Hematology
CHU Lille, Hematology Department
CHU Lille, Laboratory of Hematology
CHU Lille, Laboratory of Hematology; Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 – UMR1277 - Canther – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille
CHU Lille, Laboratory of Hematology; Univ. Lille, CNRS, Inserm, CHU Lille, IRCL, UMR9020 – UMR1277 - Canther – Cancer Heterogeneity, Plasticity and Resistance to Therapies, F-59000 Lille
Haematologica Early view Mar 20, 2025 https://doi.org/10.3324/haematol.2024.286916